1. >
  2. search-en

Search

Found 382 Results
Page 1 of 39

Annual General Meeting 2021


COMBINED GENERAL MEETING OF JUNE 10, 2021 IN CAMERA   05/05/2021 – Preliminary meeting notice published in the Official Bulletin […]

05/05/2021


Publication of the 2020 Annual Financial Report


Paris (France), April 23, 2021 – 7.00 pm CEST – Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North Copenhagen: […]

Tags:

04/23/2021


Onxeo Reports Full-Year 2020 Financial Results and Provides Business Update


Several major clinical milestones achieved in 2020 by AsiDNA™, including promising initial results in combination with chemotherapy and the launch […]

04/21/2021


Annual Financial Results 2020


The management will comment the financial results and provide an update on the Company’s activities and perspectives through a video […]

04/16/2021


Combined Annual Shareholders’ Meeting


More information coming soon 


MEET2WIN – European Oncology Partnering Convention


For more information, visit the MEET2WIN Convention website   To meet with us during the Convention, please contact bd@onxeo.com


Onxeo to Present New Preclinical Data at AACR 2021


Confirming the effect of AsiDNA™ on resistance to KRAS inhibitors Introducing OX400, a new generation of PARP interfering cancer drug […]

Tags: ,

04/08/2021


B-Smart – Interview of Judith Greciet, CEO of Onxeo


Watch the interview (in French)

03/26/2021


Onxeo will publish its annual results on April 21, 2021


The Annual General Meeting will be held on June 10, 2021 Paris (France), March 24, 2021 – 6 pm CET […]

Tags:

03/24/2021



Page 1 of 39

No more results